These molecular dynamics evolve over time: in preclinical stages, Aβ accumulation and subtle metabolic changes occur; in mild cognitive impairment (MCI), plaques and tau tangles emerge in key regions, with further metabolic decline; and in Alzheimer’s dementia, widespread pathology and severe energy deficits lead to extensive neurodegeneration [16]. The gene discussed is MAPT; the disease is Alzheimer disease.